newsfilter
← Latest News
PR Newswire·

Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of...